📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel in-vitro model of the bone marrow microenvironment in AML identifies CD44 and Focal Adhesion Kinase as therapeutic targets to reverse cell adhesion-mediated drug resistance (2024)

First Author: Ladikou E

Attributed to: Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.10.30.621120

Publication URI: http://dx.doi.org/10.1101/2024.10.30.621120

Type: Preprint